Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,718.21 +3,121.67 (+5.24%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Immunovia AB (publ) (IMMNOV.ST)
Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
At close: 05:29PM CEST
| Previous close | 1.8440 |
| Open | 1.8440 |
| Bid | 1.8620 x 0 |
| Ask | 1.8700 x 0 |
| Day's range | 1.7880 - 1.8940 |
| 52-week range | 0.5140 - 4.7300 |
| Volume | |
| Avg. volume | 746,335 |
| Market cap | 84.325M |
| Beta (5Y monthly) | 2.73 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -10.4400 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireImmunovia streamlines lab operations with move to Research Triangle Park, North Carolina
Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company seeking to increase pancreatic cancer survival through early detection, today announces that the company will move its lab and U.S. headquarters to Research Triangle Park in North Carolina in May 2024.
PR NewswireImmunovia publishes the annual report for 2023
Immunovia AB (publ) today announced that the Annual Report for 2023 has been published.
PR NewswireImmunovia Publishes Interim Report for January-March 2024
Immunovia Publishes Interim Report for January-March 2024
© 2024 Yahoo. All rights reserved.